Jason Johnson

Partner & CHS Managing Director

Overview

Jason Johnson is a partner in Crowell’s Health Care and Privacy and Cybersecurity groups, where he draws on his experience as a former research scientist to advise clients on complex compliance, legal, regulatory, and transactional matters. He helps clients, both health care and non-healthcare, navigate data privacy and cybersecurity regulatory and transactional issues under U.S. and European law. He also offers strategic insights to assist clients with product development, marketing, clinical research, and other core business initiatives.

Jason helps clients with the full range of regulatory, transactional, compliance, and intellectual property issues that arise in the research, development, and regulatory approval process, including:

  • Drafting, reviewing, negotiating, and interpreting a broad range of strategic business agreements, including collaboration, confidentiality, services, consulting, manufacturing, distribution, clinical trial, and licensing agreements;
  • Developing and implementing policies on privacy and data protection requirements, and supporting the acquisition and transfer of data, including data transfer arrangements and data use agreements for research and development activities, such as patient registries and bio-repositories;
  • Creating and implementing policies and procedures governing clinical research;
  • Advising on commercial, brand, and medical initiatives, ensuring compliance with key health care laws, regulations, and guidance, including reviewing promotional, educational, and training materials related to the company’s products;
  • Counseling clients on state and federal fraud and abuse issues, including the False Claims Act, the Stark Law, and the Anti-Kickback Statute; and
  • Advising clients on state and federal legal and regulatory issues in mergers and acquisitions and related transactions, including due diligence support.

Jason is well-versed in the most complicated federal and state regulatory challenges that his clients face. Before becoming an attorney, he worked as a bench-top scientist in academic and pharmaceutical settings, as well as a clinical research monitor for a clinical research organization. He has firsthand knowledge of clinical research rules and regulations set forth by the Food and Drug Administration, the National Institutes of Health, and institutional review boards. He employs this knowledge to assist clients with the full range of issues that arise in the research and development process.

Finally, Jason has extensive experience as a patent litigator—he has represented pharmaceutical and biotechnology companies in patent litigations for more than 11 years, giving him a unique cross-functional perspective that he uses to support his client’s business needs.

Career & Education

    • Franklin Pierce Law Center, J.D., magna cum laude
    • University of North Carolina at Chapel Hill, B.S.
    • Franklin Pierce Law Center, J.D., magna cum laude
    • University of North Carolina at Chapel Hill, B.S.
    • New York
    • U.S. District Court for the Eastern District of New York
    • U.S. District Court for the Southern District of New York
    • U.S. Patent and Trademark Office (USPTO)
    • New York
    • U.S. District Court for the Eastern District of New York
    • U.S. District Court for the Southern District of New York
    • U.S. Patent and Trademark Office (USPTO)
    • American Health Lawyers Association
    • New York State Bar Association
    • American Bar Association
    • American Health Lawyers Association
    • New York State Bar Association
    • American Bar Association

Jason's Insights

Client Alert | 5 min read | 03.28.25

HHS Announces “Dramatic Restructuring”

On March 27, 2025, HHS announced a “dramatic restructuring” of its various agencies and offices in accordance with President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” HHS also published a Fact Sheet....

Jason's Insights

Client Alert | 5 min read | 03.28.25

HHS Announces “Dramatic Restructuring”

On March 27, 2025, HHS announced a “dramatic restructuring” of its various agencies and offices in accordance with President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” HHS also published a Fact Sheet....